Ung thư bàng quang không xâm lấn và xâm lấn

Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 48: 189–199 Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48: 202–205 Advanced Bladder Cancer Meta-analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361: 1927–1934 Advanced Bladder Cancer Overview Collaboration (2005) Neoadjuvant chemotherapy for invasive bladder cancer. Cochrane Database Syst Rev 18: CD005246 Bouffioux C, Kurth KH, Bono A et al. (1995) Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomised trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. J Urol 153: 934–941 Brausi M, Collette L, Kurth K et al. (2002) EORTC Genito-Urinary Tract Cancer Collaborative Group.Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41: 523–531 Chakravarti A, Winter K, Wu CL et al. (2005) Expression of the epidermal growth factor receptor and Her-2 are predictors of favourable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology group. Int J Radiat Oncol Biophys 62(2): 309–317 Chang SS, Cole E, Cookson MS et al. (2002) Preservation of the anterior vaginal wall during female radical cystectomy with orthotopic urinary diversion: technique and results. J Urol 168: 1442–1445 Compton DA, Cleveland DW (1993) NuMA is required for proper cpmpletion of mitosis. J Cell Biol 120: 947–957 Coppin CM, Gospodarowicz MK, James K et al. (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14(11): 2901–2907 Coppin CM, Gospodarowicz MK, James K et al. (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14: 2901–2907 Dunst J, Sauer R, Schrott KM et al. (1994) Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiation Oncol Biol Physics 30: 261–266 Glas AS, Roos D, Deutekom M et al. (2003) Tumor markers in the diagnosis of primary bladder cancer. A systemic review. J Urol 169: 1975–1982 Gregoire M, Fradet Y, Meyer F et al. (1997) Diagnostic accuracy of urinary cytology and desoxyribonucleic acid flow cytometry and cytology on bladder washings during follow-up for bladder tumors. J Urol 157: 1660–1664 Gschwend JE, Dahm P, Fair WR (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41: 440–448 Gutierrez Banos JL, del Henar Rebollo Rodrigo M et al. (2001) Usefulness of the BTA stat test for the diagnosis of bladder cancer. Urology 57: 658–689 Halling KC, King W, Sokolova IA (2002) A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion for the detection of urothelial carcinoma in urine. J Uro 167: 2001–2006 Hassan JM, Cookson MS, Smith JA Jr et al. (2004) Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. J Urol 172(3): 882–884 Hautmann RE, Simon J (1999) Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men. J Urol 162: 1963–1966 Henningsohn L, Wijkstrom H, Dickman PW et al. (2002) Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 62: 215–225 Henry K, Miller J, Mori M et al. (1988) Comparison of transurethral resection to radical therapies for stage B bladder tumors. J Urol 140: 964–967 Herr HW (1987) Conservative management of muscle-infiltrating bladder cancer: prospective experience. J Urol 138: 1162–1163 Herr HW, Sogani PC (2001) Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166(4): 1296–1299 Herr HW, Donat SM, Dalbagni G (2002) Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. J Urol 168: 978–980 Holzbeierlein JM, Lopez-Corona E, Bochner BH et al. (2004) Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol 172(3): 878–881 Housset M, Maulard C, Chretien Y et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150–2157 Kaubisch S, Lum BL, Reese J et al. (1991) Stage T1 bladder cancer grade is the primary determinant for risk of muscle invasion. J Urol 146: 28 Kinders R, Jones T, Root R et al. (1998) Complement factor H or a related protein is a marker for transitional cell cancer of the bladder. Clin Can Res 4: 2511–2520 Kulkarni JN, Pramesh CS, Rathi S, Pantvaidya GH (2003) Long-term results of orthotopic neobladder reconstruction after radical cystectomy. BJU Int 91: 485–488 Lamm DL (1992) Long-term results of intravesical therapy for superficial bladder cancer. Urol Clin North Am 19: 573–580 Lamm DL, Blumenstein BA, Crissman JD et al. (2000) Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163(4): 1124–1129 Madersbacher S, Hochreiter W, Burkhard et al. (2003) Radical cystectomy for bladder cancer today – a homogeneous series without neoadjuvant therapy. J Clin Oncol 21: 690–696 Mao L, Schoenberg MP, Scicchitano M et al. (1996) Molecular detection of primary bladder cancer by microsatellite analysis. Science 271: 659–662 Oosterlinck W, Kurth KH, Schroder F et al. (1993) A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol 149(4): 749–752 Otto T, Börgermann C, Krege S, Rübben H (2001) Radical cystectomy +/-adjuvant chemotherapy in bladder cancer: a randomized phase III study. J Urol 165: 279 Poulakis V, Witzsch U, De Vries HM (2001) A comparison of nuclear matrix protein-22 and bladder tumor antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results. BJU Int 88: 692–701 Prout GR Jr, Griffm PP, Daly JJ (1987) The outcome of conservative treatment of carcinoma in situ of the bladder. J Urol 138: 766–770 Richter J, Jiang F, Görög J et al. (1997) Marked genetic differences between pTa and pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57: 2860–2864 Richter J, Beffa L, Wagner U et al. (1998) Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by CGH. Am J Pathol 153: 1615–1621 Rödel C, Grabenbauer GG, Kuhn R et al. (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20: 3061–3071 Rodel C, Weiss C, Sauer R (2005) Organ preservation by combined modality treatment in bladder cancer: the European perspective. Semin Radiat Oncol 15: 28–35 Rübben H, Bubenzer J, Bokenkamp K et al. (1979) Grading of transitional cell tumors of the urinary tract by urine cytology. Urol Res 7: 83–91 RUTT (Registry of urinary tract tumors) (1985) Harnwegstumorregister. Jahresbericht. Verh Dtsch Ges Urol 37: 665 Sarosdy MF, Hudson MA, Ellis WJ et al. (1997) Improved detection of recurrent bladder cancer using the Bard BTA stat test. Urology 50: 349–353 Sarosdy MF, Schellhammer P, Bokinsky G et al. (2002) Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168: 1950–1954 Sauer R, Birkenhake S, Kuhn R et al. (1998) Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiation Oncol Biol Physics 40: 121–127 Schilling A, Friesen A (1990) Transprostatic selective cystectomy with an ileal bladder. Eur Urol 18: 253–257 Schroeder GL, Lorenzo Gomez MF et al. (2004) A side-by-side comparison of cytology and biomarkers, HA-HAse, hematuria detection, BTA STAT, UBC-Rapid for bladder cancer detection. J Urol 172: 1123–1126 Schuster TG, Smith DC, Montie JE (2001) Pelvic recurrences post cystectomy: current treatment strategies. Semin Urol Oncol 19: 45–50 Sharp JD, Hausladen DA, Maher MG et al. (2002) Bladder cancer detection with urinary survivin, an ihibitor of apoptosis. Front Biosci 7: E36–E41 Shipley WU, Zietman AL, Kaufman DS et al. (2005) Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates – the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 15: 36–41 Simon R, Bürger H, Brinkschmidt C et al. (1998) Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 185: 345–351 Simon J, Gschwend JE, Volkmer BG (2005) Lokalrezidiv nach radikaler Zystektomie bei Harnblasenkarzinom. Urologe A 4 Solsona E, Iborra I, Ricos JV et al. (1998) Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term follow-up of a prospective study. J Urol 159: 95–98 Stein JP, Lieskovsky G, Cote R et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666–675 Steiner G, Schoenberg MP, Linn JF et al. (1997) Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med 3: 621–624 Stenzl A, Janetschek G, Bartsch G et al. (1994) Report of experience in reconstruction of the lower urinary tract in the man and woman. Urologe A 33: 9–14 Stöckle M, Alken P, Engelmann U et al. (1986) Radikale Zystektomie – Oft zu spät? Aktuel Urol 17: 234 Sylvester R, Oosterlincki W, van der Meijden A (2004) One immediate postoperative instillation of chemotherapy reduces the risk of recurrennce in patients with stage Ta T1 bladder cancer: A metaanalysis of the published results of randomized clinical trials. J Urol 171 [Suppl 71] Sylvester R, Sternberg C (2000) The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. Ann Oncol 11(7): 851–856 Tolley DA, Parmar MK, Grigor KM et al. (1996) The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol 155(4): 1233–1238 Tyrkus M, PowellI, Fakr W (1992) Cytogenetic studies of carcinoma in situ of the bladder:prognostic implications. J Urol 148: 44–46 van der Meijden AP, Sylvester RJ, Oosterlinck W et al. (2003) Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial. Eur Urol 44(4): 429–434 Varol C, Thalmann GN, Burkhard FC, Studer UE (2004) Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. J Urol 172: 937–942 Wiener HG, Vooijs GP, Hof-Grootenboer BV (1993) Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37: 163–169 Zhao J, Richter J, Wagner U et al. (1999) Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res 59: 4685–4661